BiliaryTractCancer near Safety Harbor, FL

Care Philosophy: Patients best interest comes first.

Care Philosophy: I have been in practice over seventeen years in Saint Petersburg area. My self and my office staff take a personal treatment approach for each patients seen in our office, regardless of their insurance status. Cancer is a very serious illness and I believe in giving my best of knowledge, compession and caring treatment environment to my patients. We have very caring and stable staff, who will go out of their way to help patient's need.

Care Philosophy: ``Giving of ourselves...so you receive...the best care.``

Care Philosophy: Dr. Steel served three years in the United States Air Force as Chief of_x000D_ Radiation Oncology at Kessler Medical Center in Biloxi, Mississippi._x000D_ _x000D_ Dr. Steel has performed over 4,000 prostate seed implant procedures._x000D_ Additionally, Dr. Steel has extensive training in all areas of cancer_x000D_ treatment including lung, head and neck, breast, skin and GI malignancies.

Care Philosophy: The board certified surgeons at Suncoast Surgical Associates, P.A. have accrued over twenty five years of experience caring for general and thoracic surgical patients. Providing the highest quality of care to our patients is of paramount importance. This begins with a thorough pre-operative assessment during which all options including non-operative approaches are explored and given full consideration. For those patients who require surgery, we strive to provide the safest, most advanced operati

Care Philosophy: Dr Zhang received her MD degree from the University of South Florida, Morsani College of Medicine. She completed an Internal Medicine Residency at the University of South Florida, followed by a Hematology and Medical Oncology Fellowship at Moffitt Cancer Center and the University of South Florida, where she also served as Chief Fellow. Dr Zhang is a recent recipient of the ASCO Robert A Winn Diversity in Clinical Trials Award. Dr Zhang's clinical interests focus on improving patient outcomes in non-Hodgkin lymphoma through the application of personalized cancer treatment strategies.